Tranexamic Acid for Gross Hematuria
Yes, tranexamic acid is helpful for treating gross hematuria and should be used as part of the management strategy, with the route of administration (oral, intravenous, or intravesical) tailored to the clinical context.
Evidence-Based Recommendation
The evidence supports tranexamic acid use in hematuria through multiple mechanisms and routes:
Route Selection Algorithm
For non-postoperative gross hematuria:
- Intravesical administration (1000 mg injected through Foley catheter, clamped for 15 minutes before starting continuous bladder irrigation) is highly effective and reduces ED length of stay from 411 to 274 minutes, catheter duration from 308 to 145 minutes, and revisit rates from 12.3% to 2.3% 1
- Oral tranexamic acid (500 mg twice daily, gradually increasing to 1000 mg four times daily or 1500 mg three times daily) can be used for persistent hematuria 2
For postoperative hematuria:
- Intravenous tranexamic acid shows superior outcomes in reducing hemoglobin decline and blood loss 3
For refractory prostatic bleeding:
- Intraprostatic injection of tranexamic acid can control bleeding even in patients requiring therapeutic anticoagulation 4
Specific Clinical Contexts
In patients on anticoagulants: Tranexamic acid should be administered according to the same indications as in patients not on anticoagulants (GRADE 1+, strong agreement) 5. The mechanisms of action are independent—anticoagulants and tranexamic acid act on different targets.
In ADPKD patients with persistent gross hematuria: Tranexamic acid significantly reduces hematuria duration (4 days vs. 7 days with etamsylate, p<0.001) and trends toward reduced transfusion requirements 6
Dosing specifics:
- IV: 1g bolus over 10 minutes, followed by 1g over 8 hours 7, 8
- Oral: Start 500 mg twice daily, titrate up to 1000 mg four times daily 2
- Intravesical: 1000 mg via Foley catheter, clamp 15 minutes 1
Important Caveats
Contraindications to avoid:
- Active intravascular clotting 8
- Recent thrombosis (absolute contraindication for oral use) 2
- Relative contraindications: atrial fibrillation, known thrombophilia 2
Timing considerations:
- For trauma-related bleeding, tranexamic acid must be given within 3 hours of injury—beyond this window it may be harmful 7, 9
- This 3-hour rule does NOT apply to non-traumatic hematuria
Monitoring requirements:
- Watch for thromboembolic events (deep vein thrombosis, pulmonary embolism), though rates are low (2% in large studies) 2
- Monitor for hypotension if IV administration is too rapid 8
- Discontinue if visual disturbances occur 8
Evidence Quality
A 2026 systematic review of 970 participants across seven studies demonstrated that tranexamic acid consistently reduces hemoglobin decline, blood loss, visible hematuria duration, and symptom burden 3. The evidence is strongest for postoperative hematuria with IV administration, but all routes (IV, oral, intravesical) show effectiveness.
Key distinction from ineffective uses: While tranexamic acid is ineffective for upper gastrointestinal hemorrhage (HALT-IT study) 5 and non-traumatic cerebral hemorrhage 5, these findings do not apply to urological hematuria, which has a different pathophysiology.
Practical Implementation
Start with conservative bladder irrigation and intravesical tranexamic acid for most cases of gross hematuria presenting to the emergency department. This approach provides rapid hemostasis while minimizing systemic exposure. Reserve oral therapy for persistent or recurrent cases, and IV administration for severe postoperative bleeding. The intervention works through local antifibrinolytic effects at the bleeding site, making topical/intravesical routes particularly logical for bladder sources.